Selective protein kinase inhibitors
US9168245B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2012 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Jul 24, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I or pharmaceutically acceptable salts thereof:wherein R1, R2, R3, A, Q, W and X are as defined in the description.These compounds selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant protein kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective native and/or mutant c-kit inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.